Legis Daily

Biologics Market Transparency Act of 2022

USA117th CongressS-4302| Senate 
| Updated: 5/25/2022
Tim Kaine

Tim Kaine

Democratic Senator

Virginia

Cosponsors (3)
Bill Cassidy (Republican)Roger Marshall (Republican)Margaret Wood Hassan (Democratic)

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Biologics Market Transparency Act of 2022 This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 10, 2022

Latest Companion Bill Action

HR 117-7035
Referred to the Subcommittee on Health.
May 25, 2022
Introduced in Senate
May 25, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)
  • March 10, 2022

    Latest Companion Bill Action

    HR 117-7035
    Referred to the Subcommittee on Health.
  • May 25, 2022
    Introduced in Senate
  • May 25, 2022
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)

Health

Related Bills

  • HR 117-7035: Biologics Market Transparency Act of 2022
  • S 117-4348: FDASLA Act of 2022
  • HR 117-7667: Food and Drug Amendments of 2022

Biologics Market Transparency Act of 2022

USA117th CongressS-4302| Senate 
| Updated: 5/25/2022
Biologics Market Transparency Act of 2022 This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 10, 2022

Latest Companion Bill Action

HR 117-7035
Referred to the Subcommittee on Health.
May 25, 2022
Introduced in Senate
May 25, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)
  • March 10, 2022

    Latest Companion Bill Action

    HR 117-7035
    Referred to the Subcommittee on Health.
  • May 25, 2022
    Introduced in Senate
  • May 25, 2022
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)
Tim Kaine

Tim Kaine

Democratic Senator

Virginia

Cosponsors (3)
Bill Cassidy (Republican)Roger Marshall (Republican)Margaret Wood Hassan (Democratic)

Health, Education, Labor, and Pensions Committee

Health

Related Bills

  • HR 117-7035: Biologics Market Transparency Act of 2022
  • S 117-4348: FDASLA Act of 2022
  • HR 117-7667: Food and Drug Amendments of 2022
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted